Jiangsu Hengrui Pharmaceuticals Co., Ltd. disclosed on 12 August 2026 that it repurchased 125,000 A-shares on the Shanghai Stock Exchange for its Employee Stock Ownership Schemes.

• Transaction size and pricing – Shares bought: 125,000 – Price range: RMB 54.15 – 54.41 per share – Volume-weighted average price: RMB 54.35 – Total consideration: RMB 6.79 million

• Impact on capital structure – Issued shares (excluding treasury) declined from 6.36859 billion to 6.36846 billion, a reduction of 0.002%. – Treasury shares increased from 10.41 million to 10.54 million. – Total issued shares remained unchanged at 6.38 billion, as the repurchased stock is held in treasury.

The buyback complied with all applicable listing and regulatory requirements, according to the company’s filing signed by Joint Company Secretary Liu Xiaohan.